May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” New treatments for hair loss focus on personalized and regenerative approaches for better results.
April 2026 in “Research Square” Trichoscopy is reliable for diagnosing different types of frontal non-scarring hair loss.
TSH levels are similar across nonscarring alopecia types, with unclear racial differences.
March 2026 in “Asian Journal of Medical Sciences” Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.
February 2026 in “Ciencia Latina Revista Científica Multidisciplinar” Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Low-level light therapy safely increases hair growth in various types of hair loss.
November 2025 in “SKIN The Journal of Cutaneous Medicine” "Dread shed" is common with minoxidil but less so with other hair loss treatments.
October 2025 in “Dermatology Practical & Conceptual” Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.
October 2025 in “JEADV Clinical Practice” GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.
September 2025 in “Cureus” Plica neuropathica can occur with diffuse alopecia and should be considered in diagnosis.
August 2025 in “Journal of Cosmetic Dermatology” Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.
August 2025 in “Research Square (Research Square)” High TNF-α levels may increase hair loss risk after PRP therapy.
July 2025 in “Clinical and Experimental Dermatology” Hair loss (telogen effluvium) happens before male pattern baldness.
Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.
July 2025 in “Journal of Dermatology for Physician Assistants” Specific tests may help diagnose alopecia, but their treatment impact is unclear.
July 2025 in “International Journal of Trichology” Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.
June 2025 in “British Journal of Dermatology” MS treatments can cause significant hair loss, affecting mental health.
May 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” Current treatments for non-scarring alopecia have limited effectiveness and side effects, while natural remedies may offer safer alternatives but need more research.
April 2025 in “Düzce Tıp Fakültesi Dergisi” Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.
February 2025 in “Dermatology and Therapy” Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.
February 2025 in “Brazilian Journal of Hair Health” Personalized multimodal treatment significantly improved hair growth and scalp coverage in androgenetic alopecia without side effects.
January 2025 in “International Journal of Trichology” Pattern hair loss is the most common type of alopecia.
January 2025 in “Journal of Materials Chemistry B” The microneedle patch with CuxO nanozymes effectively promotes hair growth for treating hair loss.
Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.
December 2024 in “Medical alphabet” Combining erbium laser, laser blood irradiation, and minoxidil is most effective for treating diffuse alopecia.
Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.
November 2024 in “Skin Appendage Disorders” Telogen effluvium most affects quality of life in alopecia patients.
October 2024 in “Annals of Allergy Asthma & Immunology” Anaphylaxis from cow's milk allergy can cause temporary hair loss in children.
Blood cell counts could help predict and treat alopecia areata and telogen effluvium.